Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir Plus Ribavirin in Genotype 1 and 3 Chronic HCV
NCT01896193Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Jun 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sofosbuvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Jun 2013; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01896193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01896193.